Hisamitsu Pharmaceutical Co., Inc.

    Hisamitsu Pharmaceutical Co., Inc.

    TTSE:4530
    6,040.00
    JPY
    0.00
    (0.00%)
    20.76P/E
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    TTM
    Revenue per Share
    1,666.55
    1,758.36
    1,829.68
    1,900.43
    1,726.27
    1,774.53
    1,718.12
    1,716.42
    1,401.47
    1,479.97
    1,617.47
    1,870.88
    2,119.25
    2,004.04
    Basic EPS, GAAP
    219.55
    249.3
    219.27
    208.82
    241.27
    228.52
    230.08
    227.58
    113.21
    118.92
    148
    184.43
    295.57
    195.49
    Free Cash Flow per Basic Share
    313.42
    369.3
    214.33
    302.63
    197.69
    324.07
    145.07
    288.14
    23.27
    184.77
    60.74
    68.02
    67.8
    - -
    Dividend per Share
    70.04
    70.01
    77.53
    82.98
    82.15
    81.93
    82.45
    83.22
    83.3
    84.21
    84.69
    86.85
    88.56
    - -
    Book Value per Share
    2,112.33
    2,291.63
    2,433.41
    2,573.77
    2,752.65
    2,926.13
    3,086.56
    2,914.45
    2,959.95
    3,012.63
    3,075.9
    3,314.51
    3,618.27
    3,429.11
    Tangible Book Value per Share
    1,759.9
    2,095.24
    2,401.72
    2,507.7
    2,640.76
    2,882.03
    2,954.88
    3,034.61
    3,091.88
    3,122.14
    3,245.01
    3,435.9
    3,714.39
    3,595.76
    Basic Weighted Avg Shares
    86
    86
    86
    85
    85
    84
    83
    82
    82
    81
    79
    76
    74
    75
    Sales/Revenue/Turnover
    142,772
    150,635
    156,743
    161,852
    145,925
    148,466
    143,408
    140,992
    114,510
    120,193
    128,330
    141,706
    156,006
    150,185
    Operating Margin (%)
    17.74
    12.69
    13.1
    17.13
    18.03
    18.15
    15.54
    16.12
    9.32
    7.77
    9.04
    9.29
    12.11
    9.17
    Depreciation Expense
    7,593
    7,492
    7,613
    8,545
    7,368
    6,005
    5,742
    4,251
    4,079
    4,321
    4,952
    5,172
    6,335
    - -
    Net Income, GAAP
    18,809
    21,357
    18,784
    17,784
    20,395
    19,119
    19,204
    18,694
    9,250
    9,658
    11,742
    13,969
    21,758
    14,650
    Effective Tax Rate (%)
    41.91
    36.07
    35.46
    35.79
    31.49
    30.21
    24.52
    27.7
    22.66
    23.87
    24.74
    24.78
    22.26
    26.57
    Profit Margin (%)
    13.17
    14.18
    11.98
    10.99
    13.98
    12.88
    13.39
    13.26
    8.08
    8.04
    9.15
    9.86
    13.95
    9.75
    Working Capital
    73,334
    97,362
    121,016
    130,763
    139,672
    155,127
    161,064
    168,196
    168,004
    168,016
    156,596
    148,084
    156,562
    148,440
    LT Debt
    1,234
    1,008
    788
    689
    608
    568
    503
    498
    390
    1,088
    897
    679
    2,382
    46
    Total Equity
    167,931
    196,305
    222,050
    226,092
    229,201
    245,224
    248,627
    250,741
    253,805
    254,882
    258,404
    267,076
    279,403
    275,924
    Return on Invested Capital (%)
    8.74
    6.37
    6.09
    7.69
    7.69
    7.74
    6.68
    6.45
    3.21
    2.75
    3.34
    3.71
    5.27
    3.61
    Return on Capital (%)
    10.59
    11.01
    9.03
    8.13
    8.84
    7.82
    7.48
    7.35
    3.72
    3.84
    4.57
    5.37
    8.04
    5.52
    Return on Common Equity (%)
    10.78
    11.32
    9.28
    8.32
    9.03
    8.01
    7.64
    7.52
    3.84
    3.97
    4.81
    5.64
    8.41
    5.79

    Capital Structure

    JPY

    •

    in mil. unless spec.
    Feb'24
    May'25
    Aug'25
    ST Debt
    1,421
    1,071
    1,071
    LT Borrowings
    76
    59
    46
    LT Finance Leases
    603
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    76
    73
    73
    Market Capitalization
    301,181
    279,981
    304,112

    Working Capital

    JPY

    •

    in mil. unless spec.
    Feb'24
    May'25
    Aug'25
    Total Current Assets
    194,022
    194,680
    207,043
    Cash, Cash Equivalents & STI
    125,321
    122,681
    122,736
    Accounts Receivable, Net
    43,237
    42,296
    51,878
    Inventories
    21,176
    22,719
    23,004
    Total Current Liabilities
    45,938
    55,627
    58,603
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    1,421
    1,071
    1,071
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    JPY

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    2.34%
    2.2%
    4.62%
    Free Cash Flow
    64.09%
    106.66%
    -3.12%
    Net Income, GAAP
    5.11%
    10.04%
    55.76%
    Sales/Revenue/Turnover
    0.35%
    2.69%
    10.09%
    Total Cash Common Dividend
    -0.16%
    -0.94%
    -0.9%

    Quarterly Revenue

    JPY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    32,096
    34,881
    35,850
    38,879
    141,706
    2025
    35,810
    39,646
    - -
    - -
    156,006
    2026
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    JPY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    52.08
    - -
    - -
    - -
    184.43
    2025
    63.89
    - -
    - -
    - -
    295.57
    2026
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    JPY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    86.85
    2025
    - -
    - -
    - -
    - -
    88.56
    2026
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business